Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > バイオシミラー

Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO) (HV974406)

Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)
Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)
Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)
Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)
Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)
Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)
価格(USD):
スペック:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HV974406
種反応性Human
アプリケーションELISA, Bioactivity: FCM, Functional assay, Research in vivo, WB
宿主種Human
クローン性Monoclonal
アイソタイプIgG4-kappa
生物学的活性 SHR-1701 (10 ug/mL) can inhibit TGF-β signaling pathway, activate PI3K/Akt/Erk signaling pathway, rescue lymphocytes and restore the anti-tumor function of peripheral blood CD8 + T cells in patients with lung cancer [1].
テスト済みアプリケーション WB
ターゲット B7 homolog 1, B7-H1, B7H1, CD274, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, PDL1, Programmed cell death 1 ligand 1, Programmed death ligand 1, EC:2.7.11.30, TGF-beta receptor type II, TGF-beta receptor type-2, TGF-beta type II receptor, TGFBR2, TGFR-2, TbetaR-II, Transforming growth factor-beta receptor type II
エンドトキシンレベル < 10 EU/mg
純度 >95% as determined by SDS-PAGE.
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 Q9NZQ7 & P37173
形態 Liquid
保存バッファー 0.01M PBS pH 7.4.

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

製品使用情報
アプリケーション 希釈
WB 1:500-1:2000
安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
別名SHR-1701
参考文献 1. Bo Cheng, et al. Anti-PD-L1/TGF-βR fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1/PD-L1 inhibitors in lung cancer. Cancer Commun (Lond). 2022 Jan;42(1):17-36. [HV974406]
注意事項 For research use only. Not suitable for clinical or therapeutic use.
イメージ
  • Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Retlirafusp Alfa.

  • Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)

    Bioactivity

    Detects recombinant PDL1 (Catalog No: HV974011) in indirect ELISA.

  • Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)

    Western blot

    Western blot analysis was performed using anti-PDL1 monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant human PDL1 (Catalog No: HV974011)
    Lane 2: Negative control

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト